These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37899135)

  • 21. PRDM14 mediates chemosensitivity and glycolysis in drug‑resistant A549/cisplatin cells and their progenitor A549 human lung adenocarcinoma cells.
    He S; Ma X; Zheng N; Wang G; Wang M; Xia W; Yu D
    Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33355367
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Wang FM; Xu LQ; Zhang ZC; Guo Q; Du ZP; Lei Y; Han X; Wu CY; Zhao F; Chen JL
    Aging (Albany NY); 2024 Jan; 16(2):1605-1619. PubMed ID: 38244585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CEACAM6 promotes cisplatin resistance in lung adenocarcinoma and is regulated by microRNA-146a and microRNA-26a.
    Du H; Li Y; Sun R; Yuan Y; Sun S; Zhang Y
    Thorac Cancer; 2020 Sep; 11(9):2473-2482. PubMed ID: 32648688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic and immunological potential of PPM1G in lung adenocarcinoma.
    Yin R; Qu L; Wang Z; Tang J; Gu H; Wang X; Yang D; Du P; Dong M
    Mol Med Rep; 2023 Aug; 28(2):. PubMed ID: 37387407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Down-regulation of interleukin-2 predicts poor prognosis and associated with immune escape in lung adenocarcinoma.
    Hou Y; Xiang B; Yang Z; Liu J; Xu D; Geng L; Zhan M; Xu Y; Zhang B
    Int J Immunopathol Pharmacol; 2023; 37():3946320231202748. PubMed ID: 37731383
    [No Abstract]   [Full Text] [Related]  

  • 26.
    Jiang F; Shen Q; Zhang F; Fu J; Hu L; Wang J; Zhou H; Chen J; Wang Y
    DNA Cell Biol; 2022 Jun; 41(6):631-640. PubMed ID: 35612423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TYK2 is a prognostic biomarker and associated with immune infiltration in the lung adenocarcinoma microenvironment.
    He A; Zhang R; Wang J; Huang Z; Liao W; Li Y; Wang C; Yang J; Feng Q; Wu L
    Asia Pac J Clin Oncol; 2022 Apr; 18(2):e129-e140. PubMed ID: 33852776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TAGAP expression influences CD4+ T cell differentiation, immune infiltration, and cytotoxicity in LUAD through the STAT pathway: implications for immunotherapy.
    Xu Z; Zheng T; Zheng Z; Jiang W; Huang L; Deng K; Yuan L; Qin F; Sun Y; Qin J; Li S
    Front Immunol; 2023; 14():1224340. PubMed ID: 37744350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective poly adenylation predicts the efficacy of immunotherapy in patients with lung adenocarcinoma by multiple omics research.
    Wu L; Zhong Y; Yu X; Wu D; Xu P; Lv L; Ruan X; Liu Q; Feng Y; Liu J; Li X
    Anticancer Drugs; 2022 Oct; 33(9):943-959. PubMed ID: 35946526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CCNE1 Promotes Progression and is Associated with Poor Prognosis in Lung Adenocarcinoma.
    Ma G; Yang L; Dong J; Zhang L
    Curr Pharm Biotechnol; 2022; 23(9):1168-1178. PubMed ID: 34792009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene landscape and correlation between B-cell infiltration and programmed death ligand 1 expression in lung adenocarcinoma patients from The Cancer Genome Atlas data set.
    Ho KH; Chang CJ; Huang TW; Shih CM; Liu AJ; Chen PH; Cheng KT; Chen KC
    PLoS One; 2018; 13(12):e0208459. PubMed ID: 30521597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value and immune regulatory role of dynamin 1-like in lung adenocarcinoma.
    Song W; Wu X; Wang S; Barr MP; Rodríguez M; Oh IJ; Wu Y; Li D
    Transl Lung Cancer Res; 2023 Dec; 12(12):2476-2493. PubMed ID: 38205213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Knockdown of circ‑PVT1 inhibits the progression of lung adenocarcinoma and enhances the sensitivity to cisplatin via the miR‑429/FOXK1 signaling axis.
    Cao L; Zhou X; Ding X; Gao D
    Mol Med Rep; 2021 Oct; 24(4):. PubMed ID: 34328193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Identification and Analysis of SND1 as an Oncogene and Prognostic Biomarker 
for Lung Adenocarcinoma].
    Zhang R; Huang H; Zhu G; Wu D; Chen C; Cao P; Ding C; Liu H; Chen J; Li Y
    Zhongguo Fei Ai Za Zhi; 2024 Jan; 27(1):25-37. PubMed ID: 38296623
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Significance of CD80 as a Prognostic and Immunotherapeutic Biomarker in Lung Adenocarcinoma.
    Feng W; He Z; Shi L; Zhu Z; Ma H
    Biochem Genet; 2023 Oct; 61(5):1937-1966. PubMed ID: 36892747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune-Related miRNA-195-5p Inhibits the Progression of Lung Adenocarcinoma by Targeting Polypyrimidine Tract-Binding Protein 1.
    Duan L; Wang J; Zhang D; Yuan Y; Tang L; Zhou Y; Jiang X
    Front Oncol; 2022; 12():862564. PubMed ID: 35600383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-147b promotes lung adenocarcinoma cell aggressiveness through negatively regulating microfibril-associated glycoprotein 4 (MFAP4) and affects prognosis of lung adenocarcinoma patients.
    Feng YY; Liu CH; Xue Y; Chen YY; Wang YL; Wu XZ
    Gene; 2020 Mar; 730():144316. PubMed ID: 31884109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High expression of keratin 6C is associated with poor prognosis and accelerates cancer proliferation and migration by modulating epithelial-mesenchymal transition in lung adenocarcinoma.
    Hu HB; Yang XP; Zhou PX; Yang XA; Yin B
    Genes Genomics; 2020 Feb; 42(2):179-188. PubMed ID: 31768767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpression of PELP1 in Lung Adenocarcinoma Promoted E
    Zhang D; Dai J; Pan Y; Wang X; Qiao J; Sasano H; Zhao B; McNamara KM; Guan X; Liu L; Zhang Y; Chan MSM; Cao S; Liu M; Song S; Wang L
    Pathol Oncol Res; 2021; 27():582443. PubMed ID: 34257530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of eIF6 as a prognostic factor that drives tumor progression and predicts arsenic trioxide efficacy in lung adenocarcinoma.
    Shen Y; Zhang R; Li X
    Mol Biol Rep; 2023 Feb; 50(2):1167-1180. PubMed ID: 36435920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.